Physician profile
Sarah Patrick
NPI 1114279031
$447.12
in general payments reported to CMS, 2019-2025
9 companies · $14.27 in 2025
The $14.27 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $140 · 2022: $280 · 2023: $12.78 · 2025: $14.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $27.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $27.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $109.64 | 2021-2022 | |
| Lilly USA, LLC | $106.35 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $60.27 | 2022-2025 | |
| Novo Nordisk INC | $54.91 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $38.43 | 2021-2022 | |
| Glaxosmithkline, LLC. | $35.87 | 2021-2022 | |
| Pfizer INC. | $17.83 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.64 | 2021 | |
| Amarin Pharma, INC. | $11.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Patrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.